You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TLF

Showing 1 - 25 of 333
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Calculi Trial in Rochester (Laser lithotripsy (SP TLF), Laser lithotripsy (Ho:YAG))

Recruiting
  • Urinary Calculi
  • Laser lithotripsy (SP TLF)
  • Laser lithotripsy (Ho:YAG)
  • Rochester, New York
  • +1 more
Sep 8, 2021

Spinal Stenosis Lumbar Trial in Denizli (Reposition error (RE), pain at target positions of RE and flexibility of the TLF were

Completed
  • Spinal Stenosis Lumbar
  • Reposition error (RE), pain at target positions of RE and flexibility of the TLF were assesed with iphone tiltmeter app, VAS and goniometric platform, respectively.
  • Denizli, Turkey
    Denizli State Hospital
Sep 19, 2022

In-stent Restenosis, Major Adverse Cardiovascular Events Trial in Beijing (PCSK9 inhibitor, Statin)

Recruiting
  • In-stent Restenosis
  • Major Adverse Cardiovascular Events
  • Beijing, Beijing, China
    Beijing Anzhen Hospital
Jan 16, 2023

Coronary Disease Trial in Florence (IVL procedures)

Not yet recruiting
  • Coronary Disease
  • IVL procedures
  • Florence, Italy
    University Hospital Careggi Florence
Jul 8, 2022

Coronary Restenosis Trial in Hasselt, Massy (SELUTION SLR™ DEB, Control)

Recruiting
  • Coronary Restenosis
  • SELUTION SLR™ DEB
  • Control
  • Hasselt, Belgium
  • +1 more
Nov 10, 2022

Diabetes, Coronary Artery Disease, Acute Coronary Syndrome Trial in Mexico City (Abluminus Sirolimus Eluting Stent System

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Abluminus Sirolimus Eluting Stent System (ASES)
  • Orsiro Sirolimus Eluting Coronary Stent System (OSES)
  • Mexico City, Tlalpan, Mexico
    Instituto Nacional de Cardiología Ignacio Chávez
Mar 8, 2022

DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of

Not yet recruiting
  • Coronary Artery Disease
  • DynamX Novolimus-eluting Coronary Bioadaptor System
  • (no location specified)
Oct 6, 2023

A U.S Post Approval Study Evaluating SYNERGY XLV Stent System

Active, not recruiting
  • Atherosclerosis
  • +3 more
  • SYNERGY XLV (Megatron) Coronary Stent System
  • New Haven, Connecticut
  • +7 more
Jan 20, 2023

Coronary Artery Disease Trial in Milano (DES+DCB)

Enrolling by invitation
  • Coronary Artery Disease
  • DES+DCB
  • Milano, Italy
    Istituto Clinico S.Ambrogio
Dec 4, 2022

Chronic Total Occlusive Lesions CMR Study

Recruiting
  • Chronic Total Occlusion
  • +2 more
  • Percutaneous coronary intervention
  • Beijing, Beijing, China
    Beijing anzhen hospital
Jan 16, 2023

Coronary Artery Disease, Atherosclerosis, Coronary, Myocardial Ischemia Trial (DREAMS 3G RMS, Xience DES)

Not yet recruiting
  • Coronary Artery Disease
  • +5 more
  • DREAMS 3G RMS
  • Xience DES
  • (no location specified)
Sep 12, 2022

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified

Not yet recruiting
  • Coronary Artery Disease
  • Shockwave Medical Coronary IVL System
  • (no location specified)
Mar 2, 2023

NAVISCORE PMCF Study ( rEPIC04F )

Recruiting
  • Coronary Artery Disease
  • Ischemic Heart Disease
  • Naviscore
  • Huelva, Spain
    Hospital Universitario Juan Ramon Jimenez
Jan 31, 2023

Coronary Artery Disease Trial in United Kingdom (BioMatrix Alpha)

Not yet recruiting
  • Coronary Artery Disease
  • BioMatrix Alpha
  • Birmingham, United Kingdom
  • +5 more
Mar 23, 2023

Coronary Artery Disease, Myocardial Infarction Trial (IVL with Shockwave C2+ 2Hz Coronary IVL Catheter)

Not yet recruiting
  • Coronary Artery Disease
  • Myocardial Infarction
  • IVL with Shockwave C2+ 2Hz Coronary IVL Catheter
  • (no location specified)
Jul 28, 2023

Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction Trial in Korea, Republic of (CX-ISAR, Orsiro,

Completed
  • Stable Angina
  • +2 more
  • 3-months DAPT
  • 1-year DAPT
  • Busan, Korea, Republic of
  • +11 more
Jan 8, 2023

Essential Pro PMCF Study ( rEPIC04E )

Recruiting
  • Coronary Artery Disease (CAD)
  • Ischemic Heart Disease
  • Essential pro
  • Algeciras, Spain
  • +6 more
Nov 30, 2022

Coronary Arteriosclerosis Trial in Hangzhou, Shanghai (OrbusNeich Scoreflex TRIO, OrbusNeich Scoreflex NC)

Recruiting
  • Coronary Arteriosclerosis
  • OrbusNeich Scoreflex TRIO
  • OrbusNeich Scoreflex NC
  • Hangzhou, Zhejiang, China
  • +3 more
Jun 23, 2023

Coronary Artery Disease Trial in Shanghai (BuMA Supreme)

Active, not recruiting
  • Coronary Artery Disease
  • BuMA Supreme
  • Shanghai, China
    Zhongshan Hospital
Sep 10, 2021

Coronary Artery Disease Trial in Australia, Taiwan, United States (ABT NG DES 48 EECSS)

Active, not recruiting
  • Coronary Artery Disease
  • ABT NG DES 48 EECSS
  • Scottsdale, Arizona
  • +28 more
Mar 28, 2022

Coronary Heart Disease, Drug Eluting Stent Trial (Absorbable zinc alloy drug eluting coronary stent system)

Not yet recruiting
  • Coronary Heart Disease
  • Drug Eluting Stent
  • Absorbable zinc alloy drug eluting coronary stent system
  • (no location specified)
Jul 26, 2022

Navitian PMCF Study ( rEPIC04C )

Recruiting
  • Coronary Artery Disease (CAD)
  • Ischemic Heart Disease
  • Navitian
  • Barcelona, Spain
  • +2 more
Nov 21, 2022

RESOLUTE ONYX Post-Approval Study

Completed
  • Coronary Artery Disease
  • Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
  • Huntsville, Alabama
  • +27 more
Oct 25, 2022

Coronary Artery Disease, Coronary Stenosis, Stent Restenosis Trial in Torino (Percutaneous coronary intervention with the

Recruiting
  • Coronary Artery Disease
  • +4 more
  • Percutaneous coronary intervention with the following platforms: Orsiro; Mistent; BioMime; Supraflex Cruz
  • Torino, Italy
    Fabrizio D'Ascenzo
Jan 19, 2022

Ischemic Heart Disease Trial in Seoul (Implanatation of Genoss DES sirolimus-eluting coronary system, Implanatation of Xience

Recruiting
  • Ischemic Heart Disease
  • Implanatation of Genoss DES sirolimus-eluting coronary system
  • Implanatation of Xience DES everolimus-eluting coronary system
  • Seoul, Korea, Republic of
    Cardiac and Vascular Center; Samsung Medical Center
Jun 29, 2022